Skip to main content

AI assistant

Sign in to chat with this filing

The assistant answers questions, extracts KPIs, and summarises risk factors directly from the filing text.

CervoMed Inc. Director's Dealing 2014

Jun 17, 2014

34364_dirs_2014-06-17_80597006-4f9f-4a61-ae04-2168bd6efedf.zip

Director's Dealing

Open in viewer

Opens in your device viewer

SEC Form 3 — Initial Statement of Beneficial Ownership

Issuer: RestorGenex Corp (RESX)
CIK: 0001053691
Period of Report: 2014-06-09

Reporting Person: Boris Timothy (VP Legal Affairs & Secretary)

Holdings (Derivative)

Security Exercise Price Expiration Underlying Shares Ownership
Stock Option (right to buy) $4.15 2019-06-02 Common Stock (76795) Direct

Footnotes

F1: The option will vest in equal quarterly installments for three years following the date of grant of June 3, 2014